Associated disorders

The PARK2 gene is associated with autosomal recessive Parkinson disease 2 (PARK2) (MedGen UID: 401500).

Order single gene


Order this gene as a single gene test.

Order a test

Invitae tests that include this gene:

PARK2 causes recessive, juvenile-onset Parkinson’s disease, a disorder that sometimes has dystonia as a clincial feature.

PARK2 encodes parkin, an E3 ubiquitin ligase involved in proteasome-dependent degradation of proteins. Parkin is also involved with the degradation of damaged mitochondria.

Assay and technical information

Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).

Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence, and select noncoding variants. Our assay provides a Q30 quality-adjusted mean coverage depth of 350x (50x minimum, or supplemented with additional analysis). Variants classified as pathogenic or likely pathogenic are confirmed with orthogonal methods, except individual variants that have high quality scores and previously validated in at least ten unrelated samples.

Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.

Gene Transcript reference Sequencing analysis Deletion/Duplication analysis
PARK2 NM_004562.2